These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 28223934)

  • 1. Plasma Cystatin C and High-Density Lipoprotein Are Important Biomarkers of Alzheimer's Disease and Vascular Dementia: A Cross-Sectional Study.
    Wang R; Chen Z; Fu Y; Wei X; Liao J; Liu X; He B; Xu Y; Zou J; Yang X; Weng R; Tan S; McElroy C; Jin K; Wang Q
    Front Aging Neurosci; 2017; 9():26. PubMed ID: 28223934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined measurement of plasma cystatin C and low-density lipoprotein cholesterol: A valuable tool for evaluating progressive supranuclear palsy.
    Weng R; Wei X; Yu B; Zhu S; Yang X; Xie F; Zhang M; Jiang Y; Feng ZP; Sun HS; Xia Y; Jin K; Chan P; Wang Q; Gao X
    Parkinsonism Relat Disord; 2018 Jul; 52():37-42. PubMed ID: 29574085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of blood-brain barrier-related blood-borne factors for Alzheimer's disease vs. vascular dementia diagnosis: A pilot study.
    Gong M; Jia J
    Front Neurosci; 2022; 16():949129. PubMed ID: 36003963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contra-Directional Expression of Serum Homocysteine and Uric Acid as Important Biomarkers of Multiple System Atrophy Severity: A Cross-Sectional Study.
    Chen D; Wei X; Zou J; Wang R; Liu X; Xu X; Lu J; Wang Z; Tang B; Wang B; Jin K; Wang Q
    Front Cell Neurosci; 2015; 9():247. PubMed ID: 26217177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid neurogranin and YKL-40 as biomarkers of Alzheimer's disease.
    Janelidze S; Hertze J; Zetterberg H; Landqvist Waldö M; Santillo A; Blennow K; Hansson O
    Ann Clin Transl Neurol; 2016 Jan; 3(1):12-20. PubMed ID: 26783546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychiatric symptoms and functional status in Alzheimer's disease and vascular dementia patients.
    D'Onofrio G; Sancarlo D; Panza F; Copetti M; Cascavilla L; Paris F; Seripa D; Matera MG; Solfrizzi V; Pellegrini F; Pilotto A
    Curr Alzheimer Res; 2012 Jul; 9(6):759-71. PubMed ID: 22715983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uric Acid and High-Density Lipoprotein Cholesterol Are Differently Associated with Alzheimer's Disease and Vascular Dementia.
    Liu H; Reynolds GP; Wei X
    J Alzheimers Dis; 2020; 73(3):1125-1131. PubMed ID: 31884488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the behavioral and psychological symptoms between Alzheimer's disease and vascular dementia: are the different pharmacologic treatment strategies justifiable?
    Kim JM; Lyons D; Shin IS; Yoon JS
    Hum Psychopharmacol; 2003 Apr; 18(3):215-20. PubMed ID: 12672174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychiatric profiles of patients with Alzheimer's disease and vascular dementia in Taiwan.
    Hsieh CJ; Chang CC; Lin CC
    Int J Geriatr Psychiatry; 2009 Jun; 24(6):570-7. PubMed ID: 19051223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miRNAs Plasma Profiles in Vascular Dementia: Biomolecular Data and Biomedical Implications.
    Ragusa M; Bosco P; Tamburello L; Barbagallo C; Condorelli AG; Tornitore M; Spada RS; Barbagallo D; Scalia M; Elia M; Di Pietro C; Purrello M
    Front Cell Neurosci; 2016; 10():51. PubMed ID: 26973465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Executive Dysfunction-Related Activities of Daily Living Disability and Clinical Dementia Rating Domain Patterns in Patients With Vascular Dementia and Age-Matched Patients With Alzheimer's Dementia.
    Jun BS; Kim KM; Yang HJ; Park JH
    Psychiatry Investig; 2023 Dec; 20(12):1126-1132. PubMed ID: 38163651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of the functional independence measure for assessment of patients with Alzheimer's disease and vascular dementia.
    Tanaka N; Nakatsuka M; Ishii H; Nakayama R; Hosaka R; Meguro K
    Psychogeriatrics; 2013 Dec; 13(4):199-205. PubMed ID: 24289460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia.
    Paragh G; Balla P; Katona E; Seres I; Egerházi A; Degrell I
    Eur Arch Psychiatry Clin Neurosci; 2002 Apr; 252(2):63-7. PubMed ID: 12111338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mean platelet volume and platelet distribution width in vascular dementia and Alzheimer's disease.
    Liang QC; Jin D; Li Y; Wang RT
    Platelets; 2014; 25(6):433-8. PubMed ID: 24175580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regularized Linear Discriminant Analysis of EEG Features in Dementia Patients.
    Neto E; Biessmann F; Aurlien H; Nordby H; Eichele T
    Front Aging Neurosci; 2016; 8():273. PubMed ID: 27965568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased plasma levels of soluble low density lipoprotein receptor-related protein-1 (sLRP) and the soluble form of the receptor for advanced glycation end products (sRAGE) in the clinical diagnosis of Alzheimer's disease.
    Liang F; Jia J; Wang S; Qin W; Liu G
    J Clin Neurosci; 2013 Mar; 20(3):357-61. PubMed ID: 23228658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small dense low-density lipoprotein and carotid atherosclerosis in relation to vascular dementia.
    Watanabe T; Koba S; Kawamura M; Itokawa M; Idei T; Nakagawa Y; Iguchi T; Katagiri T
    Metabolism; 2004 Apr; 53(4):476-82. PubMed ID: 15045695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific Patterns of White Matter Alterations Help Distinguishing Alzheimer's and Vascular Dementia.
    Palesi F; De Rinaldis A; Vitali P; Castellazzi G; Casiraghi L; Germani G; Bernini S; Anzalone N; Ramusino MC; Denaro FM; Sinforiani E; Costa A; Magenes G; D'Angelo E; Gandini Wheeler-Kingshott CAM; Micieli G
    Front Neurosci; 2018; 12():274. PubMed ID: 29922120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of Factors Affecting Apathy in Three Major Types of Dementia.
    Akyol MA; Küçükgüçlü Ö; Yener G
    Noro Psikiyatr Ars; 2020 Jun; 57(2):120-125. PubMed ID: 32550777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
    Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.